These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37002158)

  • 21. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
    Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
    Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms.
    Almasi F; Dang W; Mohammadipanah F; Li N
    Arch Pharm Res; 2022 Dec; 45(12):909-937. PubMed ID: 36441470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
    Curreli F; Ahmed S; Victor SMB; Drelich A; Panda SS; Altieri A; Kurkin AV; Tseng CK; Hillyer CD; Debnath AK
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062273
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Chandra A; Chaudhary M; Qamar I; Singh N; Nain V
    J Biomol Struct Dyn; 2022 Sep; 40(14):6534-6544. PubMed ID: 33583328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle.
    Owen L; Laird K; Shivkumar M
    Lett Appl Microbiol; 2022 Sep; 75(3):476-499. PubMed ID: 34953146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19.
    Adem Ş; Eyupoglu V; Sarfraz I; Rasul A; Zahoor AF; Ali M; Abdalla M; Ibrahim IM; Elfiky AA
    Phytomedicine; 2021 May; 85():153310. PubMed ID: 32948420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
    Agostini ML; Andres EL; Sims AC; Graham RL; Sheahan TP; Lu X; Smith EC; Case JB; Feng JY; Jordan R; Ray AS; Cihlar T; Siegel D; Mackman RL; Clarke MO; Baric RS; Denison MR
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study.
    Askari FS; Ebrahimi M; Parhiz J; Hassanpour M; Mohebbi A; Mirshafiey A
    Future Virol; 2022 Jul; ():. PubMed ID: 35983350
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus.
    Zhang Y; Gao H; Hu X; Wang Q; Zhong F; Zhou X; Lin C; Yang Y; Wei J; Du W; Huang H; Zhou H; He W; Zhang H; Zhang Y; McCormick PJ; Fu J; Wang D; Fu Y; Lu X; Zhang T; Duan J; Qin B; Jiang H; Luo J; Zhang Y; Chen Q; Luo Q; Cheng L; Zhang Z; Zhang J; Li J
    J Virol; 2022 Jan; 96(1):e0125321. PubMed ID: 34586857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options.
    Sohrab SS; Suhail M; Kamal MA; Azhar EI
    Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
    Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
    J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low molecular weight chitooligosaccharide inhibits infection of SARS-CoV-2 in vitro.
    Jang D; Lee D; Shin YC; Lee JS; Jung J; Ryoo S
    J Appl Microbiol; 2022 Aug; 133(2):1089-1098. PubMed ID: 35543341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice.
    Kim EH; Lee BW; Ryu B; Cho HM; Kim SM; Jang SG; Casel MAB; Rollon R; Yoo JS; Poo H; Oh WK; Choi YK
    Antiviral Res; 2022 Aug; 204():105371. PubMed ID: 35777669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
    Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
    J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances in Natural Products with Antiviral Activities.
    Sun ZG; Li ZN; Miao XW; Li S; Zhu HL
    Mini Rev Med Chem; 2021; 21(14):1888-1908. PubMed ID: 33663367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescent quantum dots enable SARS-CoV-2 antiviral drug discovery and development.
    Gorshkov K; Susumu K; Wolak M; Oh E
    Expert Opin Drug Discov; 2022 Mar; 17(3):225-230. PubMed ID: 34817309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting natural products against SARS-CoV-2.
    Al-Harrasi A; Behl T; Upadhyay T; Chigurupati S; Bhatt S; Sehgal A; Bhatia S; Singh S; Sharma N; Vijayabalan S; Palanimuthu VR; Das S; Kaur R; Aleya L; Bungau S
    Environ Sci Pollut Res Int; 2022 Jun; 29(28):42404-42432. PubMed ID: 35362883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico approach for identifying natural lead molecules against SARS-COV-2.
    Gupta SS; Kumar A; Shankar R; Sharma U
    J Mol Graph Model; 2021 Jul; 106():107916. PubMed ID: 33892297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of 2-aminoquinolone acid derivatives as potent inhibitors of SARS-CoV-2.
    Shin YS; Lee JY; Jeon S; Myung S; Gong HJ; Kim S; Kim HR; Jeong LS; Park CM
    Bioorg Med Chem Lett; 2023 Apr; 85():129214. PubMed ID: 36870624
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Sureja DK; Shah AP; Gajjar ND; Jadeja SB; Bodiwala KB; Dhameliya TM
    ChemistrySelect; 2022 Jul; 7(28):e202202069. PubMed ID: 35942360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.